Harry A. Milman

743 total citations
39 papers, 582 citations indexed

About

Harry A. Milman is a scholar working on Biochemistry, Cancer Research and Molecular Biology. According to data from OpenAlex, Harry A. Milman has authored 39 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biochemistry, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Harry A. Milman's work include Amino Acid Enzymes and Metabolism (13 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Biochemical and Molecular Research (6 papers). Harry A. Milman is often cited by papers focused on Amino Acid Enzymes and Metabolism (13 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Biochemical and Molecular Research (6 papers). Harry A. Milman collaborates with scholars based in United States and Austria. Harry A. Milman's co-authors include David A. Cooney, Hiremagalur N. Jayaram, Stewart Sell, Eugene Elmore, Richard J. Rosenbluth, Ralph E. Truitt, Carl M. Peterson, Andrew Sivak, Kenneth C. Chu and David L. Story and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Harry A. Milman

39 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry A. Milman United States 16 277 142 106 73 67 39 582
Shannon Sullivan United States 10 305 1.1× 68 0.5× 48 0.5× 33 0.5× 6 0.1× 13 583
Tetsuya Iida Japan 13 313 1.1× 70 0.5× 136 1.3× 24 0.3× 7 0.1× 20 877
Jochen Kleineke Germany 15 480 1.7× 30 0.2× 114 1.1× 39 0.5× 8 0.1× 25 817
Dianne Walker United Kingdom 9 143 0.5× 61 0.4× 55 0.5× 26 0.4× 4 0.1× 9 428
D Russell United States 7 583 2.1× 23 0.2× 348 3.3× 20 0.3× 16 0.2× 12 1.1k
Hee-Jeong Choi South Korea 6 348 1.3× 54 0.4× 65 0.6× 15 0.2× 9 0.1× 7 492
Motoaki Takayanagi Japan 16 252 0.9× 26 0.2× 23 0.2× 25 0.3× 22 0.3× 53 760
R. Sklar United States 15 580 2.1× 176 1.2× 54 0.5× 5 0.1× 14 0.2× 29 898
Catherine A. Taylor Canada 13 404 1.5× 52 0.4× 96 0.9× 11 0.2× 9 0.1× 21 637
Guadalupe Palencia Mexico 15 245 0.9× 89 0.6× 11 0.1× 18 0.2× 23 0.3× 26 711

Countries citing papers authored by Harry A. Milman

Since Specialization
Citations

This map shows the geographic impact of Harry A. Milman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry A. Milman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry A. Milman more than expected).

Fields of papers citing papers by Harry A. Milman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry A. Milman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry A. Milman. The network helps show where Harry A. Milman may publish in the future.

Co-authorship network of co-authors of Harry A. Milman

This figure shows the co-authorship network connecting the top 25 collaborators of Harry A. Milman. A scholar is included among the top collaborators of Harry A. Milman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry A. Milman. Harry A. Milman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Milman, Harry A.. (2007). Possible Contribution of Indomethacin to the Carcinogenicity of Nongenotoxic Bladder Carcinogens That Cause Bladder Calculi. Drug and Chemical Toxicology. 30(3). 161–166. 2 indexed citations
2.
Hotchkiss, Andrew K., et al.. (2004). Aggressive behavior increases after termination of chronic sildenafil treatment in mice. Physiology & Behavior. 83(5). 683–688. 28 indexed citations
3.
Milman, Harry A., Maarten C. Bosland, Paul D. Walden, & John E. Heinze. (2002). Evaluation of the Adequacy of Published Studies of Low-Dose Effects of Bisphenol A on the Rodent Prostate for Use in Human Risk Assessment. Regulatory Toxicology and Pharmacology. 35(3). 338–346. 21 indexed citations
4.
Milman, Harry A., et al.. (2002). Neurologic, Psychological, and Aggressive Disturbances with Sildenafil. Annals of Pharmacotherapy. 36. 1129–1134. 7 indexed citations
5.
Tyson, C.A., et al.. (1989). Correlation between in vivo and in vitro toxicity of some chlorinated aliphatics. Toxicology in Vitro. 3(2). 145–150. 3 indexed citations
6.
Milman, Harry A., David L. Story, Edward S. Riccio, et al.. (1988). Rat Liver Foci and in Vitro Assays to Detect Initiating and Promoting Effects of Chlorinated Ethanes and Ethylenesa. Annals of the New York Academy of Sciences. 534(1). 521–530. 25 indexed citations
7.
Murray, Teresa A., et al.. (1985). In vitro transformation of cells by chlorinated ethanes and ethylenes. Cancer Letters. 28(1). 85–92. 20 indexed citations
8.
Freeman, Gustave & Harry A. Milman. (1984). Markers of chemically induced cancer. 1 indexed citations
9.
Pal, Bikas C., Robert H. Ross, & Harry A. Milman. (1984). Nutritional requirements and contaminant analysis of laboratory animal feeds. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 268(6875). 1159–60. 3 indexed citations
10.
Milman, Harry A. & Carl M. Peterson. (1984). Apparent correlation between structure and carcinogenicity of phenylenediamines and related compounds.. Environmental Health Perspectives. 56. 261–273. 15 indexed citations
11.
Milman, Harry A., Richard F. Muth, & David A. Cooney. (1979). Aminomalonic Acid and Its Congeners as Potential in vivoInhibitors of L-Asparagine Synthetase. Enzyme. 24(1). 36–47. 5 indexed citations
12.
Milman, Harry A., et al.. (1979). Role of pancreatic L-asparagine synthetase in homeostasis of L-asparagine.. American Journal of Physiology-Endocrinology and Metabolism. 236(6). E746–E746. 11 indexed citations
13.
Milman, Harry A., John C. Peckham, Jerrold M. Ward, & Robert E. Tarone. (1979). Reduction of the severity of nephropathy in aging Fischer 344 rats treated with analogs of arylsulfonylurea. Toxicology and Applied Pharmacology. 49(3). 425–430. 1 indexed citations
14.
Milman, Harry A. & David A. Cooney. (1979). Partial purification and properties of l-asparagine synthetase from mouse pancreas. Biochemical Journal. 181(1). 51–59. 25 indexed citations
15.
Cooney, David A., Harry A. Milman, Ritchard G. Cable, et al.. (1978). Maleimide—Biochemical, pharmacologic and toxicologic studies. Biochemical Pharmacology. 27(2). 151–166. 6 indexed citations
16.
Cooney, David A., et al.. (1978). Potential Antitumor Agents via Inhibitors of L-Asparagine Synthetase: Substituted Sulfonamides and Sulfonyl Hydrazides Related to Glutamine. Journal of Pharmaceutical Sciences. 67(11). 1550–1553. 5 indexed citations
17.
Milman, Harry A., David A. Cooney, & Ritchard G. Cable. (1978). Maleimide II—interaction with l-asparaginase from Escherichia coli. Biochemical Pharmacology. 27(5). 824–826. 3 indexed citations
18.
Cooney, David A., John S. Driscoll, Harry A. Milman, Hiremagalur N. Jayaram, & Ruth D. Davis. (1976). Inhibitors of L-asparagine synthetase, in vitro.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 60(10). 1493–557. 6 indexed citations
19.
Cooney, David A., Hiremagalur N. Jayaram, Harry A. Milman, et al.. (1976). DON, CONV and DONV—III. Pharmacologic and toxicologic studies. Biochemical Pharmacology. 25(16). 1859–1870. 17 indexed citations
20.
Cooney, David A. & Harry A. Milman. (1972). A radiometric technique for measuring l-asparagine in picomol quantities. Biochemical Journal. 129(4). 953–960. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shannon Sullivan Breakdown of academic impact, for papers by Tetsuya Iida Breakdown of academic impact, for papers by Jochen Kleineke Breakdown of academic impact, for papers by Dianne Walker Breakdown of academic impact, for papers by D Russell Breakdown of academic impact, for papers by Hee-Jeong Choi Breakdown of academic impact, for papers by Motoaki Takayanagi Breakdown of academic impact, for papers by R. Sklar Breakdown of academic impact, for papers by Catherine A. Taylor Breakdown of academic impact, for papers by Guadalupe Palencia
Rankless by CCL
2026